ICH E6 (R3) Revisions: Universal Guidelines To Help Streamline The Process
Source: Remarque Systems
Since 1990, the International Council for Harmonization (ICH) of Technical Requirements for Pharmaceuticals for Human Use has undertaken a global effort to:
- Minimize the use of animal testing, all without compromising safety and effectiveness
- Improve the efficiency of new drug development
- Prevent duplication of clinical trials in humans
The guidelines are developed through a five-phase, consensus-driven process, bringing together the concerns and insights of both regulators and industry. Download this infographic to learn more.
access the Infographic!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader